Supporting Information - AWS

Report 2 Downloads 73 Views
Supporting Information Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Non-Small Cell Lung Cancer Imalka Munaweera1‡, Yi Shi2‡, Bhuvaneswari Koneru2, Ruben Saez3, Ali Aliev1, Anthony J. Di Pasqua2*, Kenneth J. Balkus Jr.1*

1

Department of Chemistry, University of Texas at Dallas, 800 West Campbell Rd., Richardson, TX 75080, United States

2

Depatment of Pharmaceutical Sciences, University of North Texas System College of Pharmacy, University of North Texas Health Science Center, 3500 Camp Bowie Blvd., Fort Worth, TX 76107, United States

3

Texas Health Research and Education Institute, Plano, TX 75093, United States

E-mail: [email protected], [email protected]

Page S1

Figure S1. PXRD pattern of (a) HoIG powder (b) Fe5Ho3O12; JCPDS 00-023-0282

Figure S2. Digital image of HoIG powder attracted to a magnet

Page S2

Figure S3. Crystal structure (cubic, Ia3d) of garnet calculated using the crystallographic data in reference 1 Holmium iron garnet (HoIG) is a member of the isostructural garnet family and ferrimagnetic oxides. The general formula for a garnet is C3A2D3O12 where the C cations occupy dodecahedral sites, the A cations occupy octahedral sites, and the D cations occupy tetrahedral sites in the crystal structure as shown in Figure S3. In the case of HoIG; (Ho3)C{Fe2}D[Fe3]AO12, 24Ho3+ occupies dodecahedral sites and 16Fe3+ occupies octahedral sites and 24Fe3+ occupies tetrahedral sites.2

Page S3

Figure S4. FTIR spectra of (a-1, b-1, c-1) HoIG, (a-2) HoIG-cisplatin, (b-2) HoIGcarboplatin, (c-2) HoIG-oxaliplatin, (a-3) cisplatin, (b-3) carboplatin, (c-3) oxaliplatin

Figure S5. The platinum drugs and possible ligand interaction with the HoIG

Page S4

Figure S6. EDX mapping and spectrum of cisplatin loaded HoIG

Figure S7. EDX mapping and spectrum of carboplatin loaded HoIG

Page S5

Figure S8. EDX mapping and spectrum of oxaliplatin loaded HoIG

Figure S9. First order model for drug release from (a) HoIG-cisplatin (b) HoIG-carboplatin (c) HoIG -oxaliplatin

References [1] T. Komori, T. Sakakura, Y. Takenaka, K.Tanaka, T.Okuda, Acta Crystallogr. Sect. E. 2009, 65, 72. [2] M. S. Lataifeh, J. Phys. Soc. Jpn. 2000, 69, 2280.

Page S6